Society recognises outstanding achievements in microscopy, imaging and flow cytometry

Thermo fisher scientific discusses the role of process analytical technology in addressing the process challenges concerning fermentation and cell culture in biotechnology and enhancing quality and speed production

Recent advancements in MALDI mass spectrometry imaging are transforming disease understanding and treatment. This innovation promises rapid diagnostics and personalised medicine, with reliable imaging within five years

IPT caught up with Peter O’Toole, president of the Royal Microscopical Society, to hear how his first few months as president have gone, his plans for the Society and how the field of microscopy might develop over the next few years

IPT talks to Yama Abassi at Agilent about immunology and cell analysis and how these will develop in the future

Droplet-based single-cell analysis systems provide an invaluable tool to accelerate research and development. Recent scientific advances enhance the applicability of these droplet-based systems to address the age-old problem of characterising, understanding and selecting cells

Www.mmc-series.org.uk

The pharmaceutical industry is seeking new ways to accelerate the drug development process, to generate both time and cost savings. How is nuclear magnetic resonance spectroscopy helping to improve the drug development sector?

Flow cytometry is a powerful technology in the emerging cell and gene therapies (CGT) field and plays a significant role in various stages in the adoptive cell therapies, but what are its advantages and limitations?

rAAV vectorology is being optimised to allow for highly specific expression and greater efficacy – how is this being achieved, and why is it so important?

Recent developments in gene therapy and the approval of mrna vaccines for treating diseases has seen the biopharmaceutical industry’s need for more well-characterised rna and oligonucleotides than ever before. How are more nucleic acid sequences being analysed by mass spectrometry (ms) through the development of new technologies, and how can innovations in software process data fully automate the workflow of the confirmation of oligonucleotide sequences based on intact ms/ms

IPT recently spoke with Xiaobo Wang at Agilent about what’s been driving demand for flow cytometry and where the technology might be heading